NDC 61958-2101 – Odefsey
Emtricitabine 200 mg/1; Rilpivirine Hydrochloride 25 mg/1; Tenofovir Alafenamide Fumarate 25 mg/1 · Tablet · Oral
Product NDC61958-2101
Product details
- Brand name
- Odefsey
- Generic name
- emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA208351
- Marketed since
- March 1, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Emtricitabine 200 mg/1
- Rilpivirine Hydrochloride 25 mg/1
- Tenofovir Alafenamide Fumarate 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-2101-1 | 30 TABLET in 1 BOTTLE, PLASTIC (61958-2101-1) | Mar 1, 2016 |